Clinical Trial Update: Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI

View source ↗

Summary

A clinical trial update on validating new biomarkers to predict no-reflow in STEMI patients undergoing primary PCI, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• No-reflow Phenomenon

Snippet

Sponsor: Assiut University | Conditions: Myocardial Infarction, No Reflow Phenomenon | Status: NOT_YET_RECRUITING